You are here: Industry Insights > Akers Biosciences

News List

Akers Biosciences, Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results americanpharmaceuticalreview
August 28, 2020
Akers Biosciences announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conducted during a 4 week test of its SARS-CoV-2 vaccine candidate in mice.
Akers, Premas Biotech Announce Successful Completion of Vaccine Prototype americanpharmaceuticalreview
May 20, 2020
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, has successfully completed its vaccine prototype.
Akers Biosciences, Premas Biotech Announce Progress in its Vaccine Development for COVID-19 americanpharmaceuticalreview
April 10, 2020
Akers Biosciences announced its collaboration with Premas Biotech has successfully completed the milestone of obtaining clones of all three coronavirus antigens, Spike (S) ...
Akers, Premas Progress Covid-19 Vax Development contractpharma
April 07, 2020
Akers Biosciences collaboration with Premas Biotech has successfully completed the milestone of obtaining clones of all three coronavirus antigens, Spike (S), Envelope (E), and Membrane (M) that they have selected for their vaccine candidate.
Akers Biosciences Licenses Premas Coronavirus Vax Candidate contractpharma
March 26, 2020
Aims to accelerate development timeline leveraging the D-Crypt platform.